Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tod J Merkel

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Infection and Immunity|August 22, 2018
Histopathology of Bordetella pertussis in the Baboon ModelLindsey I Zimmerman, James F Papin, Jason Warfel, et al.
Genome Announcements|June 13, 2015
Complete Genome Sequence of Bordetella pertussis D420Christine J Boinett, Simon R Harris, Gemma C Langridge, et al.
Infection and Immunity|October 29, 2008
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge modelCrystal L Loving, Taruna Khurana, Manuel Osorio, et al.
Msphere|October 23, 2024
A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challengeParul Kapil, Yihui Wang, Kelsey Gregg, et al.
Frontiers in Microbiology|March 22, 2024
The contribution of BvgR, RisA, and RisS to global gene regulation, intracellular cyclic-di-GMP levels, motility, and biofilm formation in <i>Bordetella bronchiseptica</i>Tracy L Nicholson, Ursula Waack, Damarius S Fleming, et al.
Scientific Reports|September 14, 2016
The multifaceted RisA regulon of Bordetella pertussisLoïc Coutte, Ludovic Huot, Rudy Antoine, et al.
Plos One|May 10, 2013
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infectionRebecca A Brady, Christopher P Mocca, Ranjani Prabhakara, et al.
Human Vaccines & Immunotherapeutics|June 22, 2013
Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infectionTod J Merkel, Pin-Yu Perera, Gloria M Lee, et al.
The Journal of Infectious Diseases|March 15, 2014
Pertussis pathogenesis--what we know and what we don't knowErik L Hewlett, Drusilla L Burns, Peggy A Cotter, et al.
Infection and Immunity|March 24, 2010
Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal traffickingJanaki K Iyer, Taruna Khurana, Marybeth Langer, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Infection and Immunity|August 22, 2018
Histopathology of Bordetella pertussis in the Baboon ModelLindsey I Zimmerman, James F Papin, Jason Warfel, et al.
Genome Announcements|June 13, 2015
Complete Genome Sequence of Bordetella pertussis D420Christine J Boinett, Simon R Harris, Gemma C Langridge, et al.
Infection and Immunity|October 29, 2008
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge modelCrystal L Loving, Taruna Khurana, Manuel Osorio, et al.
Msphere|October 23, 2024
A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challengeParul Kapil, Yihui Wang, Kelsey Gregg, et al.
Frontiers in Microbiology|March 22, 2024
The contribution of BvgR, RisA, and RisS to global gene regulation, intracellular cyclic-di-GMP levels, motility, and biofilm formation in <i>Bordetella bronchiseptica</i>Tracy L Nicholson, Ursula Waack, Damarius S Fleming, et al.
Scientific Reports|September 14, 2016
The multifaceted RisA regulon of Bordetella pertussisLoïc Coutte, Ludovic Huot, Rudy Antoine, et al.
Plos One|May 10, 2013
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infectionRebecca A Brady, Christopher P Mocca, Ranjani Prabhakara, et al.
Human Vaccines & Immunotherapeutics|June 22, 2013
Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infectionTod J Merkel, Pin-Yu Perera, Gloria M Lee, et al.
The Journal of Infectious Diseases|March 15, 2014
Pertussis pathogenesis--what we know and what we don't knowErik L Hewlett, Drusilla L Burns, Peggy A Cotter, et al.
Infection and Immunity|March 24, 2010
Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal traffickingJanaki K Iyer, Taruna Khurana, Marybeth Langer, et al.
Pageof 5